New clip device aims to fix leaky heart valve without open surgery

NCT ID NCT07509658

Recruiting now Disease control Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is checking how well the TriClip device works and how safe it is for people in Japan with a leaky tricuspid valve. The device is already approved for use, and this study will follow 250 patients to confirm its benefits in everyday medical practice. The main goal is to see if the valve leakage is reduced to moderate or less within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TriClip System (a device that clips the tricuspid valve to reduce leakage)
What this could lead to: If successful, this study could confirm that the TriClip device works safely in Japanese patients, offering a less invasive treatment option for tricuspid regurgitation.
What could go wrong: This is an observational study, not a randomized trial, so results may be less definitive. The device is already approved, but long-term benefits and risks in this population are still being confirmed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tricuspid valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRICUSPID REGURGITATION

Contacts and locations

Locations

National Cerebral & Cardiovascular Center Hospital
RECRUITING

Suita, Osaka, 564-8565, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.